간 외 담관암의 수술과 방사선 치료의 효과
The effect of curative surgical resection and adjuvant radiotherapy in patients with extrahepatic bile duct cancer
2
조회
0
다운로드
0
인용
0
참고문헌
초록
Background/Aims: To evaluate the effect and prognostic factors related to curative surgical resection and adjuvant radiotherapy in patients with extrahepatic bile duct cancer. Methods: The authors performed a retrospective analysis of 53 patients with extrahepatic bile duct cancer who were treated at Chungnam National University Hospital between 1998 and 2005. 18 patients (Group 1) were managed with percutaneous bile drainage (n=13) or endoscopic bile drainage (n=5), 17 patients (Group 2) underwent only curative resection, and 18 patients (Group 3) received radiotherapy after curative resection. The radio-sensitizer used in these patients was 5-FU. Results: Three-year overall survival was 5.6% in group 1, 64.7% in group 2, and 61.1% in group 3, with no significant difference noted between group 2 and group 3. The disease-free survival rate was 64.7% in group 2 and 66.7% in group 3, with no significant difference noted between the two groups. We evaluated age, sex, differentiation, tumor location, perineural invasion, operative method, lymphovascular tumor emboli, T stage, and N stage as possible prognostic factors. T stage, N stage, and operative method were significant factors in group 2, but age was the only significant factor in group 3. Group 2 patients had longer overall survival than did group 3 patients with well-differentiated cancer, but group 3 patients had longer survival than did group 2 patients with lymph node metastasis. The recurrence rate was 34.3% (mean value) and was no different between group 2 and group 3. Recurrence sites included local tissue, such as liver, and regional lymph nodes. There were no serious complications during radiotherapy. Conclusions: Patients who underwent curative surgical resection and adjuvant radiotherapy after surgery had no statistically significant difference in survival or recurrent rates. However, curative surgery is considered to be the only method to improve survival. Our results suggest that radiotherapy after curative resection may improve survival in patients with lymph node metastasis. (Korean J Med 75:194-201, 2008)
Abstract
Background/Aims: To evaluate the effect and prognostic factors related to curative surgical resection and adjuvant radiotherapy in patients with extrahepatic bile duct cancer. Methods: The authors performed a retrospective analysis of 53 patients with extrahepatic bile duct cancer who were treated at Chungnam National University Hospital between 1998 and 2005. 18 patients (Group 1) were managed with percutaneous bile drainage (n=13) or endoscopic bile drainage (n=5), 17 patients (Group 2) underwent only curative resection, and 18 patients (Group 3) received radiotherapy after curative resection. The radio-sensitizer used in these patients was 5-FU. Results: Three-year overall survival was 5.6% in group 1, 64.7% in group 2, and 61.1% in group 3, with no significant difference noted between group 2 and group 3. The disease-free survival rate was 64.7% in group 2 and 66.7% in group 3, with no significant difference noted between the two groups. We evaluated age, sex, differentiation, tumor location, perineural invasion, operative method, lymphovascular tumor emboli, T stage, and N stage as possible prognostic factors. T stage, N stage, and operative method were significant factors in group 2, but age was the only significant factor in group 3. Group 2 patients had longer overall survival than did group 3 patients with well-differentiated cancer, but group 3 patients had longer survival than did group 2 patients with lymph node metastasis. The recurrence rate was 34.3% (mean value) and was no different between group 2 and group 3. Recurrence sites included local tissue, such as liver, and regional lymph nodes. There were no serious complications during radiotherapy. Conclusions: Patients who underwent curative surgical resection and adjuvant radiotherapy after surgery had no statistically significant difference in survival or recurrent rates. However, curative surgery is considered to be the only method to improve survival. Our results suggest that radiotherapy after curative resection may improve survival in patients with lymph node metastasis. (Korean J Med 75:194-201, 2008)
참고문헌 (20)
- 2002 Annual Report of the Korea Central Cancer Registry, "Korean Central Cancer Registry", Korean Central Cancer Registry, ~ (2002)
- Bae KB, "Surgical treatment and prognosis for 268 patients with biliary track cancers", J Korean Surg Soc, 58, pp.412~419 (2000)
- Cho BD, "Clinical characteristics and prognosis of the extrahepatic bile duct cancer", Korean J Gastroenterol, 28, pp.251~259 (1996)
- Sakamoto Y, "Prognostic factors of surgical resection in middle and distal bile duct cancer: an analysis of 55 patients concerning the significance of ductal and radial margins", Surgery, 137, pp.396~402 (2005)
- Sasaki R, "Prognostic significance of lymph node involvement in middle and distal bile duct ca", Surgery, 129, pp.677~683 (2001)
- Eom JW, "Analysis of survival rate of the gall bladder and extrahepatic bile duct cancer", J Korean Surg Soc, 48, pp.531~541 (1995)
- Hong IN, "Resected extrahepatic bile duct cancers", J Korean Surg Soc, 7, pp.232~241 (1994)
- Launois B, "Proximal bile duct cancer: high resectability rate and 5-year survival", Ann Surg, 230, pp.266~275 (1999)
- Jang JY, "Actual long-term outcome of extrahepatic bile duct cancer after surgical resection", Ann Surg, 241, pp.77~84 (2005)
- Pichlmayr R, "Surgical treatment in proximal bile duct cancer: a single center experience", Ann Surg, 224, pp.628~638 (1996)
- Kim WC, "The role of postoperative radiation therapy in extrahepatic bile duct cancers", J Korean Soc Ther Radiol Oncol, 21, pp.118~124 (2003)
- Choi Y, "Treatment outcome of postoperative radiotherapy in extrahepatic bile duct cancer", J Korean Soc Ther Radiol Oncol, 21, pp.27~34 (2003)
- Kopelson G, "The role of radiation therapy in cancer of the extrahepatic biliary system: an analysis of thirteen patients and a review of the literature of the effectiveness, of surgery, chemotherapy and radiotherapy", Int J Radiat Oncol Biol Phys, 2, pp.883~894 (1977)
- Kim S, "Role of postoperative radiotherapy in the management of extrahepatic bile duct cancer", Int J Radiat Oncol Biol Phys, 54, pp.414~419 (2002)
- Han WS, "The effect of adjuvant therapy for curatively resected extrahepatic bile duct cancer", J Korean Cancer Assoc, 31, pp.1253~1260 (1999)
- Kurosaki H, "Intraoperative radiotherapy for resectable extrahepatic bile duct cancer", Int J Radiat Oncol Biol Phys, 45, pp.635~638 (1999)
- Morganti AG, "Combined modality treatment in unresectable extrahepatic biliary carcinoma", Int J Radiat Oncol Biol Phys, 46, pp.913~919 (2000)
- Shin HS, "Combination of external beam irradiation and high-dose rate intraluminal brachytherapy for inoperable carcinoma of the extrahepatic bile ducts", Int J Radiat Oncol Biol Phys, 57, pp.105~112 (2003)
- Kamada T, "The role of radiotherapy in the management of extrahepatic bile duct cancer: an analysis of 145 consecutive patients treated with intraluminal and", or external beam radiotherapy, 1996, pp.34, 767~774
- McMasters KM, "Neoadjuvant chemoradiation for extrahepatic cholangiocarcinoma", Am J Surg, 174, pp.605~609 (1997)